1. Home
  2. /Report-store
  3. /Food and Beverages
  4. /Agriculture and Agri Products
Report image for Global Agricultural Biotechnology Market Size, Opportunity Analysis and Forecast, 2025-2035

Global Agricultural Biotechnology Market Size, Trend & Opportunity Analysis Report, by Organism (Plants, Animals, Microbes), Application (Vaccine, Flower Culturing, Biofuels), and Forecast, 2025-2035

Report Code: FBAA112Author Name: Isha PaliwalPublication Date: August 2025Pages: 293
Available In:
Available format: PDFAvailable format: ExcelAvailable format: Word
KAISO Research and Consulting

Global Agricultural Biotechnology Market Size, Opportunity Analysis and Forecast, 2025-2035

Publication Date: Aug 16, 2025Pages: 293

Market Definition and Introduction


The Global Agricultural Biotechnology Market was valued at USD 151.23 billion in 2024 and is poised to ascend to USD 335.07 billion by 2035, growing at a CAGR of 7.5% throughout the forecast period 2025-2035. All this is happening because of the above-stated conditions under food insecurity, climate change stress on agriculture, and an ever-growing world population demanding more resilient and higher yields of crops. Biotechnology has been at the forefront as a revolutionary force in healthcare, and now it is all settled into agriculture as the lynchpin of sustainability, productivity, and efficiency. It is through engineering genes, conducting molecular diagnostics, and proceeding with synthetic biology that agricultural biotechnology is providing changes in how crops resist diseases, adapt to environmental changes, and fulfill the consumer needs of today.


The increasing application of biotechnologies in crops and livestock suggests a turning point in the concept of food systems worldwide. Precision technologies now include CRISPR-Cas9 gene editing, transgenic breeding, and microbial enhancement for developing stress-tolerant plants, disease-resistant animals, and efficient biofuel feedstocks. The pressure for low-input, high-output farming systems is mounting and propelling agricultural biotechnology toward mainstream acceptance as governments and agribusinesses seek to mitigate greenhouse gas emissions and reverse biodiversity loss.


This market further taps into data-driven agriculture coupled with genomics-assisted trait selection, which will help in shortening breeding timelines and optimizing productive outputs. The integration of digital agriculture with biological innovations would eventually lay the foundation for climate-smart farming practices. No longer is it the mere upscaling of crop yield; agricultural biotechnology has become a strategy that influences environmental conservation, food security policy, and the global push toward carbon agriculture in net-zero.


Recent Developments in the Industry


  1. In February 2025, China’s Ministry of Agriculture released a strategic plan (2024–2028) focused on enhancing food security through agricultural biotechnology. The initiative emphasizes gene-editing technologies and development of resilient crop varieties like corn, wheat, and soybeans, aiming to reduce dependency on imports and strengthen domestic crop breeding using cutting-edge molecular tools.


  1. In March 2025, UK biotech firm Tropic introduced a gene-edited banana variety that resists browning for over 12 hours after peeling. Developed using CRISPR without adding foreign DNA, this innovation addresses post-harvest waste and shelf-life concerns. It marks a significant step toward sustainable tropical fruit production through targeted genome editing.


  1. In mid‑2025, the global agricultural biotechnology market has surged to USD 60.5 billion, with projections expecting growth to USD 137.8 billion by 2034—reflecting a robust 9.6% CAGR. Innovations steering this growth include CRISPR and RNAi, AI-driven breeding, engineered microbes for soil health, and bioengineered seeds and biopesticides. These advancements highlight biotechnology’s pivotal role in addressing climate resilience, yield enhancement, and sustainable agriculture.


  1. In Early 2025, the European Commission is fast-tracking approval protocols for biopesticides and biocontrol technologies, aiming to slash the typical decade-long regulatory timeline. Under the proposed changes, EU member states would be allowed provisional product usage pending full evaluation. A broader Biotech Act planned for 2026 would solidify these reforms—addressing the urgent need for environmentally friendly alternatives and reviving Europe’s pace of agricultural innovation.


  1. In January 2024, Evogene raised US$40 million from institutional investors for the sake of strengthen its platforms that employ computational biology to discover microbial inoculants and bio-stimulants for row crops.


  1. In March 2024, ADM introduced a pilot program in collaboration with universities to evaluate bioengineered crops with high oil content directed toward renewable diesel and alternative aviation fuel production.


Market Dynamics


Rapid changes in demand for new high-efficiency crops are shaping the investment landscape in agricultural biotechnology.


An emerging urgency to grow high-yield crops with less input is invigorating the agricultural biotechnology marketplace. Climate instability, the shrinking amount of arable land, and increasing food demand lead governments and private organizations to infuse cash into developing genetically optimized seeds. Companies are developing crops with improved photosynthesis efficiency, use of nitrogen, and pest resistance, resulting in a farm-level revolution.


The implications of the new government's biosafety regulations and pro-GMO regulations were shortened cycle times of commercialization.


Countries have initiated the harmonization of biosafety regulatory frameworks as a region, especially in the Asia-Pacific and Latin America, making it easier to market GMOs and biotech-enhanced crops. For example, India has cleared field trials for many gene-edited rice and mustard strains, accelerating the process toward commercialization. The promising signs from these regulatory relaxations, following scientific risk assessments, would allow a faster pace of product development and reduced go-to-market timelines for biotech firms.


The growing use of microbial solutions and plant probiotics in sustainable agriculture is in trend.


Microbial agriculture is based on using plant growth-promoting rhizobacteria (PGPRs), mycorrhizal fungi, and N-fixing bacteria as a very powerful branch of agricultural biotechnology. These would also be important in providing an alternative to synthetic fertilizers in a chemical-free way while maintaining soil health and sustainability in the long run. Consumer pull for organically grown produce and regenerative agricultural practices is driving the use of these biotechnologies even faster at the field level.


The interface between agri-genomics and machine learning is creating a new paradigm with innovations in trait prediction as well as crop setting.


The union of all bioinformatics, AI-driven phenotyping, and genomic selection is redefining plant and animal breeding. Machine learning algorithms now sift through petaflops of genetic data to find desirable traits such as disease resistance, drought tolerance, and nutrient density. Such changes have drastically reduced the time it takes to breed and get new biotech traits to market, allowing developers to bring them to market faster than before. Thus, the competition improves in markets.


An emerging area of investment in biotechnologies directed to developing economies is anchored upon strong private-public partnerships.


The visibility of public-private partnerships is increasing across the developing world, particularly where agri-biotech has just begun to penetrate. The programs focus on knowledge and technology transfer, infrastructure for deploying solutions based on genetic engineering, and subsidizing the costs for farmers; all of these activities would build trust among farmers and help to shorten the period required for market penetration of a biotech product.


Attractive Opportunities in the Market


  1. CRISPR Gene Editing - Precision tools simplify trait development for yield, resistance, and stress adaptation
  2. Microbial Inoculants - Soil-enhancing bacteria and fungi replace synthetic agrochemicals
  3. Biofuel Advancements - Engineered crops unlock new frontiers in renewable energy feedstocks
  4. AI & Genomics - Predictive algorithms reduce breeding cycles and enhance trait accuracy
  5. Trait-Stacking in GM Crops - Multi-resistance seeds address pest and climate challenges simultaneously
  6. Sustainable Agriculture - Regulatory and consumer push toward eco-friendly farming technologies
  7. Agri-biotech Startups - Venture capital floods into computational and synthetic biology firms
  8. Floriculture Engineering - Genetically modified flowers meet aesthetic and environmental needs


Report Segmentation


By Organism: Plants, Animals, Microbes

By Application: Vaccine, Flower Culturing, Biofuels

By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)


Key Market Players: Bayer AG, Corteva Agriscience, Syngenta AG, BASF SE, ADM, Evogene Ltd., Marrone Bio Innovations, Calyxt Inc., BioConsortia Inc., and Arcadia Biosciences


Report Aspects


Base Year: 2024

Historic Years: 2022, 2023, 2024

Forecast Period: 2025-2035

Report Pages: 293


Dominating Segments


In agricultural biotechnology, the plant segment is under tremendous pressure from a global food security demand.


Plants are the basis for agricultural biotechnology since they are crucial in global food systems. The genetic modification of crops such as maize, rice, and soybean has increased production and resilience to climate stressors. Gene editing in fruits and vegetables with an extended shelf life and improved nutritional characteristics is another avenue by which food logistics and public health sectors are being transformed. The plant segment remains largely accepted, perhaps even the most commercially profitable class of organism for ag-biotech applications.


Vaccination Applications Gain Momentum with Biotech Immunization Solutions Due to Livestock Disease Outbreaks


Vaccination application is emerging as one of the greatest revenue-generating sectors, particularly given the endless diseases affecting livestock. Biotechnology could enable the production of safe, targeted animal vaccines that would halt the spread of the disease, enhance productivity, and reduce antibiotic therapy. Recent innovations include edible plant-based vaccines and low-cost DNA vaccines for easy administration to large herds, especially in poultry and cattle farming.


Rapidly Expanding Microbial Segment with Innovations in Soil Probiotics and Nitrogen Fixing Solutions


Microbes are critical for sustainable agriculture by providing biological replacements for synthetic chemicals. With expanding R&D in microbial engineering, products such as nitrogen-fixing bacteria, phosphate-solubilizing microbes, and biocontrol agents are emerging in fame. The ability of microbes to improve soil biodiversity while ensuring plant health presents this segment of ag-biotech as a leading high-growth frontier.


Key Takeaways


  1. Genetic Crop Innovation - Enhanced seed traits boost resilience and yield amid climate volatility
  2. Animal Biotech Progression - Livestock vaccines and genetic improvements reduce disease losses
  3. Microbial Breakthroughs - Soil and root microbiome enhancements promote sustainable practices
  4. Precision Agriculture - AI, genomics, and digital tools compress breeding cycles
  5. Collaborative Frameworks - Private-public R&D models accelerate ag-biotech innovation pipelines
  6. Policy-Driven Growth - Easing GMO regulations globally unlocks market access
  7. Biofuels & Sustainability - Engineered crops aid in the energy transition
  8. Floriculture Engineering - Genetically designed aesthetics meet consumer and environmental goals
  9. Asia-Pacific Momentum - Regional biosafety frameworks and production capacity drive adoption
  10. Trait-Stacking Tools - Next-gen seeds feature multiple resistance and productivity features


Regional Insights


North America Leads the Agricultural Biotechnology Market Driven by Mature Infrastructure and GM Crop Adoption


North America stands globally as a leader in agricultural biotechnology with a strong commercial focus on genetically modified crops, extensive R&D facilities, and favorable regulatory regimes. The U.S. leads with GM maize, soybean, and cotton, widely adopted and backed by a myriad of gene-editing start-ups and agri-genomics research institutions. Canada and Mexico, too, are building on biotech seeds and vaccine deployment, thereby further reinforcing the region's dominance.


Europe Accelerates Precision Biotechnology Despite Regulator Caution on GMOs


The European approach to agricultural biotechnology is influenced by multi-layered regulations and a strong environmental ethos. Even with stringent GMO regulations, recent court decisions and pilot projects have paved the way for gene-editing under non-GMO labels. Countries like Germany, the Netherlands, and France are heavily investing in microbial biotechnology and precise breeding modalities, thereby aligning innovation and sustainability aspirations within the ambit of the EU Green Deal.


Asia-Pacific Emerges as the Fastest-Growing Region with Expanding Biotech Infrastructure and Agri-Exports


Asia-Pacific is expected to have the highest CAGR for agricultural biotechnology due to the burgeoning agri-export economies, regulatory modernization, and rising public-private investments. China, India, and South Korea are at the cutting edge of gene-editing research, while Southeast Asian countries are working to develop microbial and floriculture biotech for both local food systems and export markets.


LATAM And MEA Regions Integrating Agricultural Biotechnology For Food Security And Climate Adaptation


Latin America, especially Brazil and Argentina, plays a key role in GMO cultivation and exports. Yield improvements and environmental performance have been dramatically supported by local policy frameworks put in place and access to biotech-enabled seeds. Meanwhile, in Middle Eastern and African countries, agri-biotech is being pursued for desert farming, water use efficiency, and biofuel production in regions struggling with aridity and often a lack of available arable land.


Core Strategic Questions Answered in This Report


Q. What is the expected growth trajectory of the agricultural biotechnology market from 2024 to 2035?


The global agricultural biotechnology market is projected to grow from USD 151.23 billion in 2024 to USD 335.07 billion by 2035, registering a CAGR of 7.5% during the forecast period. This upward trajectory is driven by advancements in gene-editing technologies, rising demand for climate-resilient crops, and increasing adoption of microbial and precision agriculture solutions.


Q. Which key factors are fuelling the growth of the agricultural biotechnology market?


Several key drivers are accelerating the market:

  1. Increased use of GM crops for yield and resistance enhancement
  2. Integration of digital tools and genomics in breeding programs
  3. Government support for sustainable agriculture initiatives
  4. High demand for livestock vaccines and biocontrol products
  5. Growing investments in synthetic biology and microbial solutions
  6. Rising global demand for biofuels and low-input farming systems


Q. What are the primary challenges hindering the growth of the agricultural biotechnology market?


Key obstacles include:

  1. Complex and often restrictive regulatory environments for GMOs
  2. Public skepticism around genetically engineered organisms
  3. High R&D and commercialization costs
  4. Lack of infrastructure in emerging regions
  5. IP and patent-related challenges in biotechnology innovation


Q. Which regions currently lead the agricultural biotechnology market in terms of market share?


North America leads the market due to widespread adoption of GM crops, robust research infrastructure, and advanced regulatory frameworks. Europe and Asia-Pacific follow closely, with the former emphasizing precision biotech and the latter driving innovation through scale and investment.


Q. What emerging opportunities are anticipated in the agricultural biotechnology market?


New avenues include:

  1. CRISPR-based gene-editing applications in non-GMO regulated markets
  2. Microbial seed coatings and soil-enhancing probiotics
  3. Bioengineered floriculture with custom traits
  4. Cloud-based agri-biotech R&D platforms
  5. Next-gen biofuels from genetically modified oil crops


Key Benefits for Stakeholders


  1. The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
  2. The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
  3. Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
  4. A detailed examination of market segmentation helps identify existing and emerging opportunities.
  5. Key countries within each region are analysed based on their revenue contributions to the overall market.
  6. The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
  7. The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

Chapter 1. Market Snapshot


1.1. Market Definition & Report Overview

1.2. Market Segmentation

1.3. Key Takeaways

1.3.1. Top Investment Pockets

1.3.2. Top Winning Strategies

1.3.3. Market Indicators Analysis

1.3.4. Top Impacting Factors

1.4. Industry Ecosystem Analysis

1.4.1. 360- Analysis


Chapter 2. Executive Summary


2.1. CEO/CXO Standpoint

2.2. Strategic Insights

2.3. ESG Analysis

2.4 Market Attractiveness Analysis

2.5.key Findings


Chapter 3. Research Methodology


3.1 Research Objective

3.2 Supply Side Analysis

3.2.1. Primary Research

3.2.2. Secondary Research

3.3 Demand Side Analysis

3.3.1. Primary Research

3.3.2. Secondary Research

3.4. Forecasting Models

3.4.1. Assumptions

3.4.2. Forecasts Parameters

3.5. Competitive breakdown

3.5.1. Market Positioning

3.5.2. Competitive Strength

3.6. Scope of the Study

3.6.1. Research Assumption

3.6.2. Inclusion & Exclusion

3.6.3. Limitations


Chapter 4. Industry Landscape


4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Porter-s 5 Forces Model

4.2.1. Bargaining Power of Buyer

4.2.2. Bargaining Power of Supplier

4.2.3. Threat of New Entrants

4.2.4. Threat of Substitutes

4.2.5. Competitive Rivalry

4.3. Value Chain Analysis

4.4. PESTEL Analysis

4.5. Pricing Analysis and Trends

4.6. Key growth factors and trends analysis

4.7. Market Share Analysis (2025)

4.8. Top Winning Strategies (2025)

4.9. Trade Data Analysis (Import Export)

4.10. Regulatory Guidelines

4.11. Historical Data Analysis

4.12. Analyst Recommendation & Conclusion


Chapter 5. Global Agricultural Biotechnology Market Size & Forecasts by Organism 2025-2035


5.1. Market Overview

5.1.1. Market Size and Forecast By Organism 2025-2035

5.2. Plants

5.2.1. Market definition, current market trends, growth factors, and opportunities

5.2.2. Market size analysis, by region, 2025-2035

5.2.3. Market share analysis, by country, 2025-2035

5.3. Animals

5.3.1. Market definition, current market trends, growth factors, and opportunities

5.3.2. Market size analysis, by region, 2025-2035

5.3.3. Market share analysis, by country, 2025-2035

5.4. Microbes

5.4.1. Market definition, current market trends, growth factors, and opportunities

5.4.2. Market size analysis, by region, 2025-2035

5.4.3. Market share analysis, by country, 2025-2035


Chapter 6. Global Agricultural Biotechnology Market Size & Forecasts by Application 2025-2035


6.1. Market Overview

6.1.1. Market Size and Forecast By Application 2025-2035

6.2. Vaccine

6.2.1. Market definition, current market trends, growth factors, and opportunities

6.2.2. Market size analysis, by region, 2025-2035

6.2.3. Market share analysis, by country, 2025-2035

6.3. Flower Culturing

6.3.1. Market definition, current market trends, growth factors, and opportunities

6.3.2. Market size analysis, by region, 2025-2035

6.3.3. Market share analysis, by country, 2025-2035

6.4. Biofuels

6.4.1. Market definition, current market trends, growth factors, and opportunities

6.4.2. Market size analysis, by region, 2025-2035

6.4.3. Market share analysis, by country, 2025-2035


Chapter 7. Global Agricultural Biotechnology Market Size & Forecasts by Region 2025-2035


7.1. Regional Overview 2025-2035

7.2. Top Leading and Emerging Nations

7.3. North America Agricultural Biotechnology Market

7.3.1. U.S. Agricultural Biotechnology Market

7.3.1.1. By Organism breakdown size & forecasts, 2025-2035

7.3.1.2. By Application breakdown size & forecasts, 2025-2035

7.3.2. Canada Agricultural Biotechnology Market

7.3.2.1. By Organism breakdown size & forecasts, 2025-2035

7.3.2.2. By Application breakdown size & forecasts, 2025-2035

7.3.3. Mexico Agricultural Biotechnology Market

7.3.3.1. By Organism breakdown size & forecasts, 2025-2035

7.3.3.2. By Application breakdown size & forecasts, 2025-2035

7.4. Europe Agricultural Biotechnology Market

7.4.1. UK Agricultural Biotechnology Market

7.4.1.1. By Organism breakdown size & forecasts, 2025-2035

7.4.1.2. By Application breakdown size & forecasts, 2025-2035

7.4.2. Germany Agricultural Biotechnology Market

7.4.2.1. By Organism breakdown size & forecasts, 2025-2035

7.4.2.2. By Application breakdown size & forecasts, 2025-2035

7.4.3. France Agricultural Biotechnology Market

7.4.3.1. By Organism breakdown size & forecasts, 2025-2035

7.4.3.2. By Application breakdown size & forecasts, 2025-2035

7.4.4. Spain Agricultural Biotechnology Market

7.4.4.1. By Organism breakdown size & forecasts, 2025-2035

7.4.4.2. By Application breakdown size & forecasts, 2025-2035

7.4.5. Italy Agricultural Biotechnology Market

7.4.5.1. By Organism breakdown size & forecasts, 2025-2035

7.4.5.2. By Application breakdown size & forecasts, 2025-2035

7.4.6. Rest of Europe Agricultural Biotechnology Market

7.4.6.1. By Organism breakdown size & forecasts, 2025-2035

7.4.6.2. By Application breakdown size & forecasts, 2025-2035

7.5. Asia Pacific Agricultural Biotechnology Market

7.5.1. China Agricultural Biotechnology Market

7.5.1.1. By Organism breakdown size & forecasts, 2025-2035

7.5.1.2. By Application breakdown size & forecasts, 2025-2035

7.5.2. India Agricultural Biotechnology Market

7.5.2.1. By Organism breakdown size & forecasts, 2025-2035

7.5.2.2. By Application breakdown size & forecasts, 2025-2035

7.5.3. Japan Agricultural Biotechnology Market

7.5.3.1. By Organism breakdown size & forecasts, 2025-2035

7.5.3.2. By Application breakdown size & forecasts, 2025-2035

7.5.4. Australia Agricultural Biotechnology Market

7.5.4.1. By Organism breakdown size & forecasts, 2025-2035

7.5.4.2. By Application breakdown size & forecasts, 2025-2035

7.5.5. South Korea Agricultural Biotechnology Market

7.5.5.1. By Organism breakdown size & forecasts, 2025-2035

7.5.5.2. By Application breakdown size & forecasts, 2025-2035

7.5.6. Rest of APAC Agricultural Biotechnology Market

7.5.6.1. By Organism breakdown size & forecasts, 2025-2035

7.5.6.2. By Application breakdown size & forecasts, 2025-2035

7.6. LAMEA Agricultural Biotechnology Market

7.6.1. Brazil Agricultural Biotechnology Market

7.6.1.1. By Organism breakdown size & forecasts, 2025-2035

7.6.1.2. By Application breakdown size & forecasts, 2025-2035

7.6.2. Argentina Agricultural Biotechnology Market

7.6.2.1. By Organism breakdown size & forecasts, 2025-2035

7.6.2.2. By Application breakdown size & forecasts, 2025-2035

7.6.3. UAE Agricultural Biotechnology Market

7.6.3.1. By Organism breakdown size & forecasts, 2025-2035

7.6.3.2. By Application breakdown size & forecasts, 2025-2035

7.6.4. Saudi Arabia (KSA Agricultural Biotechnology Market

7.6.4.1. By Organism breakdown size & forecasts, 2025-2035

7.6.4.2. By Application breakdown size & forecasts, 2025-2035

7.6.5. Africa Agricultural Biotechnology Market

7.6.5.1. By Organism breakdown size & forecasts, 2025-2035

7.6.5.2. By Application breakdown size & forecasts, 2025-2035

7.6.6. Rest of LAMEA Agricultural Biotechnology Market

7.6.6.1. By Organism breakdown size & forecasts, 2025-2035

7.6.6.2. By Application breakdown size & forecasts, 2025-2035


Chapter 8. Company Profiles


8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Bayer AG

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.2. Corteva Agriscience

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.3. Syngenta AG

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.4. BASF SE

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.5. Archer Daniels Midland Company (ADM)

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.6. Evogene Ltd.

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.7. Marrone Bio Innovations

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.8. Calyxt Inc.

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.9. BioConsortia Inc.

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.10. Arcadia Biosciences

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis


Research Methodology


Kaiso Research and Consulting follows an independent approach in making estimations to provide unbiased business intelligence. Our studies are not limited to secondary research alone but are built on a balanced blend of primary research, surveys, and secondary sources. This methodology enables us to develop a comprehensive 360-degree understanding of the industry and market landscape.


Supply and Demand Dynamics:


A. Supply Side Analysis:


We begin by assessing how suppliers contribute to overall market revenue growth. Our research then delves into their product portfolios, geographical reach, core focus areas, and key strategic initiatives. As most of our reports are based on a top-down approach, we begin by conducting interviews across the value chain. In the first round, we engage with manufacturers and companies, speaking with professionals from supply chain management, production, and sales. These discussions allow us to gather detailed insights into revenue generation, measured in millions or billions, segmented by type, platform, end-user, region, and other key parameters. This helps identify how companies are driving their products into mainstream markets and influencing the overall industry structure.


As the final step, we conduct a Pareto analysis to evaluate market fragmentation and identify the key players influencing industry structure. On the supply side, we evaluate how industry players contribute to overall market growth and revenue generation.


This includes an in-depth review of:


  1. Product Offerings – range, categories, and applications covered.
  2. Geographical Presence – regions of operation and market penetration.
  3. Strategic Initiatives – new product development, product launches, distribution channel strategies, and key application areas.


B. Demand Side Analysis:


Once supply dynamics are assessed, we then examine demand-side factors shaping the market. This involves mapping demand across applications, geographies, and end-user groups. On the demand side, we conduct interviews with a network of distributors from the organised market to gain a deeper understanding of demand dynamics. This analysis covers revenue generation segmented by type, platform, end-user, and region.


Each subsegment is interconnected to understand patterns in:


  1. Revenue contribution
  2. Growth rate
  3. Adoption levels


By aggregating demand from all subsegments, we estimate the magnitude of market-driving forces. Comparing supply and demand enables us to forecast how these dynamics influence future market behaviour.


Forecast Model (Proprietary Kaiso Engine):


Building on quantitative rigor, Kaiso integrates a Forecast Model that blends statistical precision with strategic scenario planning. Unlike generic projections, this model adapts dynamically to evolving market signals.


Our proprietary forecast engine incorporates the following layers:


  1. Baseline Projection: Derived using historical patterns, econometric baselines, and validated macroeconomic inputs.


  1. Scenario Forecasting: Optimistic, conservative, and base-case outlooks built with dynamic weighting of influencing variables (e.g., policy shifts, raw material volatility, supply chain disruptions).


  1. AI-Augmented Predictive Analytics: Machine learning algorithms detect emerging weak signals, nonlinear patterns, and correlation anomalies that standard models may overlook.


  1. Sector-Specific Modules: Tailored sub-models for fast-evolving industries (e.g., clean energy adoption curves, healthcare regulatory cycles, AI penetration trends).


  1. Resilience Testing: Shock modeling to evaluate market response under “black swan” or disruption scenarios such as pandemics, trade wars, or technology breakthroughs.


Deliverable outcomes of our Forecast Model:


  1. Granular projections by region, segment, and application (up to 2035)


  1. Sensitivity-rank matrices highlighting critical drivers and risks


  1. Dynamic update capability, ensuring forecasts remain current with real-time data

This ensures that our clients don’t just see where the market is heading, but also how robust that trajectory is under different conditions.


Approach & Methodology


At Kaiso Research and Consulting, we adopt an independent, data-driven approach to ensure objective and unbiased insights. Our methodology blends primary research, secondary research, and survey-based validation, giving us a 360° market perspective.



Research Phase


Description


Key Activities


Secondary Research

Gathering qualitative insights from a variety of credible sources.

Analysis of blogs, articles, presentations, interviews, annual reports, and premium databases such as Hoovers, Factiva, Bloomberg.

Primary Research Phase 1: CXO Perspective

Interviews with top-level executives to collect strategic insights on trends and market drivers.

Discussions with CEOs, CXOs, industry leaders; interpretation of executive viewpoints.

Primary Research Phase 2: Quantitative Data Generation

Data collection from key stakeholders along the value chain, segmented by supply and demand.

Step 1: Interviews with manufacturers and supply chain personnel to gauge revenue metrics.

Step 2: Interviews with distributors to assess demand-side revenues.

Primary Research Phase 3: Validation

Ground-level survey research for real-world data validation across the value chain.

Collaboration with local survey companies; engagement with manufacturers, wholesalers, retailers, and end-users.


On average, for each market:


  1. 45 primary interviews are conducted covering the entire value chain.
  2. Interviews last approximately 28 minutes each, including a mix of face-to-face and online formats.


This rigorous methodology guarantees realistic, credible, and unbiased market analysis.


Key Player Positioning


We assess key companies on two major dimensions:


Market Positioning: measured through revenue, growth rate, geographical reach, customer base, strategies implemented, and focus areas.


Competitive Strength: evaluated through product portfolio, R&D investment, innovation, new product introductions, and overall competitiveness.


Conclusion


Our comprehensive methodology enables us to deliver high-quality, objective, and actionable market intelligence. By balancing both supply and demand perspectives, Kaiso Research and Consulting has established itself as a trusted and recognised brand in the research and consulting landscape.


IDENTIFY GROWTH & OPPORTUNITY

Gain actionable insights to capture market opportunities and stay ahead of the competition.

Consultation

Tailor this report to your exact business needs with our customization service.

Kaiso Logo
Location IconOffice 205 N Michigan Ave, Chicago, Illinois 60601, USA
YouTubeInstagramLinkedIn

We Accept

Payment MethodPayment MethodPayment MethodPayment MethodPayment MethodPayment Method

About

  • About us
  • What We Believe
  • Our Mission
  • Blogs & News

Company

  • Privacy Policy
  • Terms & Conditions
  • GDPR Policy
  • Disclaimer
  • Return & Refund Policy
  • Delivery Formats
  • Cookie Policy

Contact Us

  • Request for Consultation
  • Contact Us
  • Career
  • How to Order
  • Become a Reseller
  • FAQs

Contact Detail

Phone icon+1 872 219 0417
Phone icon+91 91835 80078
Email icon[email protected]

Keep in touch

Sign up for emails

Services

    Syndicate Reports
    Custom Report Solutions
    Full Time Engagement Models (FTE)
    Strategic Growth Solutions
    Consulting Services

Industries

    Popular Reports

      Healthcare IT
      Consumer Electronics
      Renewable and Specialty Chemicals
      Engineering, Equipment and Machinery
      Nutraceuticals and Wellness Foods
      Green, Alternative, and Renewable Energy

      Semiconductors
      Electric and Hybrid Vehicles
      Enterprise and Consumer IT Solutions
      Commercial Aviation
      Financial Services

    © 2025 Kaiso Research and Consulting. All Rights Reserved.

    ISO 9001 : 2015

    Privacy PolicyTerms & ConditionsHow to OrderSiteMap
    +1 872 219 0417+91 91835 80078
    [email protected]
    KAISO Logo
    Services
    Dropdown
    Industries
    Dropdown
    Report StoreConsulting Services
    Dropdown
    Blogs & NewsAbout Us
    Dropdown
    Logo
    Search
    Services►
    Industries►
    Report Store
    Consulting Services►
    Blogs & News
    About Us►